Phillyrin Modulates AMPK‐Associated Cellular Responses and Migration in PC3 Prostate Cancer Cells
Journal of Toxicology · 2026-01 · 2026 (1)
DOI: 10.1155/jt/2022957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Toxicology, online erschienen am 11.04.2026. Verfasst von Cheng-Hsin Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Penghu Hospital, Magong, Penghu, Taiwan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Armed Forces General Hospital.
Abstract (Originalsprache)
Males with prostate cancer exhibit substantial mortality and metastasis; however, few effective treatment strategies are available for advanced prostate cancer. Phillyrins (PHNs) are lignan glycosides that have been reported to exhibit diverse biological activities, including potential anticancer effects. We aimed (1) to assess the effect of PHN on PC3 prostate cancer cells and (2) to examine cellular responses associated with its activity. To assess the effects of PHN, it was exposed to various concentrations of PHN (1, 2.5, and 5 μM) for 24 h. A wound‐healing assay was performed to evaluate cell migration. Western blotting and immunofluorescence were used to investigate the expression of adenosine monophosphate–activated protein kinase (AMPK)–associated proteins and transcription factors involved in epithelial–mesenchymal transition (EMT). PHN exposure was associated with reduced migratory capacity of PC3 cells under noncytotoxic conditions. PHN exposure was associated with decreased α‐smooth muscle actin, Snail, and Slug expression while increasing E‐cadherin expression. Sirtuin 1 (SIRT1) and nuclear respiratory factor 1 (NRF1) protein levels were upregulated in PHN‐treated cells, accompanied by changes in AMPK protein expression. Pharmacological inhibition with Compound C attenuated PHN‐associated changes in EMT‐related marker expression in PC3 cells. Thus, PHN exposure may influence EMT‐associated phenotypes in PC3 cells, potentially involving AMPK‐associated signaling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Penghu Hospital, Magong, Penghu, Taiwan.
- Division of Urology, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan, edah.org.tw.
- Department of Chemical Engineering and Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan, isu.edu.tw.
- Department of Nursing, I-Shou University, Kaohsiung, Taiwan, isu.edu.tw.
- Department of Medical Laboratory Science and Biotechnology, Chung-Hwa University of Medical Technology, Tainan, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, isu.edu.tw.
ORCID-Profile: Cheng-Hsin Lu, Hsing-Chia Mai, Victor C Lin, Chiang-Ting Wang
Förderung
- Kaohsiung Armed Forces General Hospital
Zitieren
APA
Lu, C. H., Wu, C. H., Hsieh, P. F., Wu, R. C., Mai, H. C., Huang, W. L., Chen, S. H., Lai, C. M., Lin, V. C., & Wang, C. T. (2026). Phillyrin Modulates AMPK‐Associated Cellular Responses and Migration in PC3 Prostate Cancer Cells. Journal of Toxicology, 2026(1). https://doi.org/10.1155/jt/2022957
Vancouver
Lu CH, Wu CH, Hsieh PF, Wu RC, Mai HC, Huang WL, et al. Phillyrin Modulates AMPK‐Associated Cellular Responses and Migration in PC3 Prostate Cancer Cells. Journal of Toxicology. 2026;2026(1). doi:10.1155/jt/2022957
BibTeX
@article{Lu2026,
author = {Lu, Cheng-Hsin and Wu, Chun-Hsien and Hsieh, Pei-Fang and Wu, Richard Chen-Yu and Mai, Hsing-Chia and Huang, Wei-Lun and Chen, Sih-Han and Lai, Chien-Ming and Lin, Victor C and Wang, Chiang-Ting},
title = {Phillyrin Modulates AMPK‐Associated Cellular Responses and Migration in PC3 Prostate Cancer Cells},
journal = {Journal of Toxicology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jt/2022957}
}
EUVIMED